Clinical Trial

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

Study acronym: ACACIA
Completed Phase 2
View on ClinicalTrials.gov →
Summary
This clinical trial is being conducted to learn about safety and tolerability of digoxin in ALS individuals. Additionally, this trial aims to better understand if digoxin has an effect on slowing neurodegeneration in ALS.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-31
notable Primary completion pushed: 2026-03 -> 2026-04-13 2026-07-31
minor Completion pushed: 2026-04 -> 2026-05-13 2026-07-31
Trial Details
NCT Number NCT07047209
Lead Sponsor Massachusetts General Hospital
Conditions ALS (Amyotrophic Lateral Sclerosis)
Enrollment 41 participants
Start Date 2025-05-27
Primary Completion 2026-04-13 (estimated)
Study Completion 2026-05-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-30